Small Molecule Injectable Drugs Market By Drug Class (Small Molecule Antibiotics, Chemotherapy Agents, Skeletal Muscle Relaxants, Analgesics, Anticoagulants, Anticonvulsants, Antivirals and Others), By Indication (Oncology, Pain Management, Cardiovascular Diseases, Infectious Diseases, CNS Diseases and Others), By Mode of Delivery (Intravenous, Subcutaneous and Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Jan 2025
- Report ID: 137117
- Number of Pages: 356
- Format:
-
keyboard_arrow_up
-
-
- Aurobindo Pharma Limited
- Teva Pharmaceutical Industries Ltd. Company Profile
- Merck & Co. Inc.
- AstraZeneca Plc Company Profile
- Pfizer Inc Company Profile
- Sun Pharmaceutical Industries Ltd.
- Novartis AG Company Profile
- Baxter International Inc Company Profile
- Fresenius Kabi
- Cipla Limited Company Profile
- Mylan N.V.
- Sanofi S.A
- Dr. Reddys Laboratories Ltd Company Profile
- Other players
- settingsSettings
Our Clients
- 137117
- Jan 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
